Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis

Abstract Background PSMA PET/CT has shown excellent results in imaging of prostate cancer. However, some nonprostatic malignancies can also demonstrate 18 F-PSMA uptake, including primary lung cancer. 18 F-FDG PET/CT is widely employed in initial staging, response to therapy and follow-up assessment...

Full description

Bibliographic Details
Main Authors: Yuan Hu, Peng Wang, Wenli Dai
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12890-023-02377-9
_version_ 1827985264231841792
author Yuan Hu
Peng Wang
Wenli Dai
author_facet Yuan Hu
Peng Wang
Wenli Dai
author_sort Yuan Hu
collection DOAJ
description Abstract Background PSMA PET/CT has shown excellent results in imaging of prostate cancer. However, some nonprostatic malignancies can also demonstrate 18 F-PSMA uptake, including primary lung cancer. 18 F-FDG PET/CT is widely employed in initial staging, response to therapy and follow-up assessment for lung cancer. Here we present an interesting case report on the different patterns of PSMA and FDG uptake between primary lung cancer and metastatic intrathoracic lymph node metastases in a patient with concurrent metastatic prostate cancer. Case presentation A 70-year-old male underwent 18 F-FDG PET/CT and 18 F-PSMA-1007 PET/CT imaging due to suspicion primary lung cancer and prostate cancer. The patient eventually was diagnosed with non-small cell lung cancer (NSCLC) with mediastinal lymph node metastases and prostate cancer with left iliac lymph node and multiple bone metastases. Interestingly, our imaging revealed different patterns of tumor uptake detected on 18 F-FDG and 18 F-PSMA-1007 PET/CT in primary lung cancer and lymph node metastases. The primary lung lesion showed intense FDG uptake, and mild uptake with 18 F-PSMA-1007. Whereas the mediastinal lymph node metastases showed both intense FDG and PSMA uptake. The prostate lesion, left iliac lymph node, and multiple bone lesions showed significant PSMA uptake and negative FDG uptake. Conclusion In this case, there was a homogeneity of 18 F-FDG intense uptake between LC and metastatic lymph nodes, but a heterogeneity in 18 F-PSMA-1007 uptake. It illustrated that these molecular probes reflect the diversity of tumor microenvironments, which may help us understand the differences of the tumor response to treatment.
first_indexed 2024-04-09T23:12:08Z
format Article
id doaj.art-9b1069dc49ed410da583e15bd1b56a8d
institution Directory Open Access Journal
issn 1471-2466
language English
last_indexed 2024-04-09T23:12:08Z
publishDate 2023-03-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj.art-9b1069dc49ed410da583e15bd1b56a8d2023-03-22T10:18:59ZengBMCBMC Pulmonary Medicine1471-24662023-03-012311510.1186/s12890-023-02377-9Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasisYuan Hu0Peng Wang1Wenli Dai2Department of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges UniversityDepartment of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges UniversityDepartment of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges UniversityAbstract Background PSMA PET/CT has shown excellent results in imaging of prostate cancer. However, some nonprostatic malignancies can also demonstrate 18 F-PSMA uptake, including primary lung cancer. 18 F-FDG PET/CT is widely employed in initial staging, response to therapy and follow-up assessment for lung cancer. Here we present an interesting case report on the different patterns of PSMA and FDG uptake between primary lung cancer and metastatic intrathoracic lymph node metastases in a patient with concurrent metastatic prostate cancer. Case presentation A 70-year-old male underwent 18 F-FDG PET/CT and 18 F-PSMA-1007 PET/CT imaging due to suspicion primary lung cancer and prostate cancer. The patient eventually was diagnosed with non-small cell lung cancer (NSCLC) with mediastinal lymph node metastases and prostate cancer with left iliac lymph node and multiple bone metastases. Interestingly, our imaging revealed different patterns of tumor uptake detected on 18 F-FDG and 18 F-PSMA-1007 PET/CT in primary lung cancer and lymph node metastases. The primary lung lesion showed intense FDG uptake, and mild uptake with 18 F-PSMA-1007. Whereas the mediastinal lymph node metastases showed both intense FDG and PSMA uptake. The prostate lesion, left iliac lymph node, and multiple bone lesions showed significant PSMA uptake and negative FDG uptake. Conclusion In this case, there was a homogeneity of 18 F-FDG intense uptake between LC and metastatic lymph nodes, but a heterogeneity in 18 F-PSMA-1007 uptake. It illustrated that these molecular probes reflect the diversity of tumor microenvironments, which may help us understand the differences of the tumor response to treatment.https://doi.org/10.1186/s12890-023-02377-918F-PSMA-100718F-FDGPET/CTPrimary lung cancerLymph node metastases
spellingShingle Yuan Hu
Peng Wang
Wenli Dai
Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
BMC Pulmonary Medicine
18F-PSMA-1007
18F-FDG
PET/CT
Primary lung cancer
Lymph node metastases
title Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
title_full Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
title_fullStr Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
title_full_unstemmed Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
title_short Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
title_sort heterogeneous uptake of 18f fdg and 18f psma 1007 pet ct in lung cancer and lymph node metastasis
topic 18F-PSMA-1007
18F-FDG
PET/CT
Primary lung cancer
Lymph node metastases
url https://doi.org/10.1186/s12890-023-02377-9
work_keys_str_mv AT yuanhu heterogeneousuptakeof18ffdgand18fpsma1007petctinlungcancerandlymphnodemetastasis
AT pengwang heterogeneousuptakeof18ffdgand18fpsma1007petctinlungcancerandlymphnodemetastasis
AT wenlidai heterogeneousuptakeof18ffdgand18fpsma1007petctinlungcancerandlymphnodemetastasis